Physician

Ali Houssayn Moussa, M.D.

According to 2025 Medicare claims, Ali Moussa, M.D. (NPI: 1548207814) practices hematology/oncology in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (NPI: 1962876045; TIN: 383983999) and primary practice location at 74146-6236. Moussa is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616), participating under the MSSP model.

Moussa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,290 traditional Medicare patients, billed 211,440 HCPCS/CPT codes, and received $3,869,217 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 4,171 prescription claims across 578 beneficiaries totaling $7,163,554 in drug costs, led by Cabometyx (Cabozantinib S-Malate). DME data shows 132 claims. Open Payments data shows 22 records totaling $540. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,501,282 to $7,163,554. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $28,660 to $2,580.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	994	238,629	$2,764,274
2016	1,149	148,182	$2,705,982
2017	1,193	221,548	$3,606,586
2018	1,353	232,447	$3,882,699
2019	1,319	207,745	$3,371,586
2020	1,194	161,289	$3,354,394
2021	1,258	134,975	$2,848,835
2022	1,198	161,492	$2,879,341
2023	1,161	164,331	$3,056,701
2024	1,290	211,440	$3,869,217

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	331	2,430	$2,501,282
2016	386	2,632	$3,182,827
2017	418	2,968	$3,570,851
2018	467	3,187	$4,745,343
2019	483	3,553	$5,069,094
2020	468	3,667	$4,930,667
2021	545	3,787	$6,002,384
2022	533	4,025	$6,630,395
2023	560	4,228	$6,340,516
2024	578	4,171	$7,163,554

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	86	366	$43,381
2016	53	353	$41,464
2017	14	178	$30,683
2018	25	105	$14,073
2019	N/R	72	$5,098
2020	N/R	131	$9,606
2021	N/R	86	$5,079
2022	46	263	$14,125
2023	N/R	167	$22,595
2024	N/R	132	$12,312

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	562	2,265	$10
36415	Insertion of needle into vein for collection of blood sample	577	1,667	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	580	2,360	$8
83735	Magnesium level	527	2,207	$7
83615	Lactate dehydrogenase (enzyme) level	532	2,213	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cabometyx	Cabozantinib S-Malate	42	1,260	$1,079,912
Imbruvica	Ibrutinib	51	1,428	$810,517
Revlimid	Lenalidomide	48	1,176	$740,764
Calquence	Acalabrutinib Maleate	43	1,275	$520,004
Brukinsa	Zanubrutinib	30	900	$412,815

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	27	$6,008
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	29	$2,898
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	18	$1,859
J8521	Capecitabine, oral, 500 mg	N	N/R	25	$1,089
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	21	$251

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$540	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Houssayn Moussa, M.D.?

Tedicare shows public-source Medicare data for Ali Houssayn Moussa, M.D. (NPI 1548207814), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Houssayn Moussa, M.D. have ACO affiliation data?

Ali Houssayn Moussa, M.D. is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616).

What billing organization is linked to Ali Houssayn Moussa, M.D.?

Ali Houssayn Moussa, M.D. is linked to OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (billing NPI 1962876045) in the available physician profile data.

Does Ali Houssayn Moussa, M.D. have Open Payments data?

Ali Houssayn Moussa, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.